Clinical Use:
Background: CA 125 belongs to a family of hybridoma – defined tumour markers, it has a protein structure and possesses carbohydrate side chains. Its principle use is in monitoring the treatment of Ovarian Carcinoma.
Reference Ranges: 0 – 35 kU/L
Associated Diseases:
Patient Preparation:
Specimen Requirements: Serum (10 ul) is the recommended sample type for this assay.
Turnaround Time: 24 hours
Additional Information:
Referred Test:
Location: